21,900
employees
150
countries in which
the Group’s medicines
are distributed
20%
over 20% of revenue from
brand-name medicines invested
in R&D each year
€ 5.3 billion
euros in revenue in 2021/2022
including €4 billion for brand-name medicines and
€1.3 billion for generic activities
4 therapeutic areas
oncology, neuroscience,
immuno-inflammation,
and cardiometabolism
2nd
pharmaceutical group
worldwide in hypertension
5th
pharmaceutical group
worldwide in cardiology
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
OUR COMMITMENTS
As a Group dedicated to health care, our task is to contribute to the world in which we live.
We perceive health as a whole and strive to positively influence the individual, society and the planet through research and development.